WASHINGTON (AP) – The United States receives a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday authorized a Johnson & Johnson vaccine that works with one dose instead of two.
Health experts eagerly await unique option to speed up vaccinations as they race against virus that has already killed more more than 510,000 people in the United States and is undergoing an increasingly disturbing change.
The FDA said J & J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose protected 85% against the most serious COVID-19 disease, in a massive study that spanned three continents – protection that has remained strong even in countries like South Africa, where the most worrying variants are spreading .
“The more the vaccines that have high efficacy that we can get into the better, ”said Dr. Anthony Fauci, the leading infectious disease specialist in the United States, before the FDA decision.
Shipments of a few million doses to be distributed among the states could begin as early as Monday. At the end of March, J&J announced that it plans to deliver 20 million doses to the United States and 100 million by the summer.
J&J is also seeking authorization for the emergency use of its vaccine in Europe and from the World Health Organization. Worldwide, the company aims to produce around 1 billion doses worldwide by the end of the year. The island nation of Bahrain became the first to allow its use on Thursday.
The Associated Press’s Department of Health and Science receives support from the Department of Science Education at the Howard Hughes Medical Institute. The AP is solely responsible for all content.
- According to the source J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine.
- Check all news and articles from the Politics news updates.
Source: Twitter AP